Direct Answer
Remote patient monitoring companies supply devices and software that track vital signs and conditions at home, such as blood pressure, glucose and heart rhythm, and send data to clinicians. Revenue comes from device sales, subscriptions and billed monitoring services.
Industry Overview
Remote Patient Monitoring sits within the health care sector. The first numbers to compare across companies here are active monitored patients, revenue per patient and reimbursement code coverage. The outside forces that move them are listed under Primary Macro Drivers.
Key Industry Metrics
- Active monitored patients: Number of patients currently sending data to clinicians. Because billing depends on ongoing monitoring, this count is the main driver of recurring revenue.
- Revenue per patient: Average monthly or annual income per monitored patient from services and devices. Changes follow reimbursement rates and the number of services billed.
- Reimbursement code coverage: Whether billing codes cover the monitoring services provided and who pays for them. Revenue depends on codes remaining in force, so rule changes can alter results fast.
- Gross margin: Share of revenue left after device cost, connectivity and clinical support. Devices and clinical labor lower margins compared with pure software, so mix is important.
- Customer clinic count: Number of clinics and health systems using the service. Growth shows adoption, but depth per clinic, shown by patients enrolled, matters as much.
Primary Macro Drivers
- Medicare reimbursement for remote monitoring: Medicare payment codes for monitoring decide whether practices can bill for remote readings, so coverage changes move active patients and revenue per patient.
- Chronic disease prevalence: More patients with conditions such as high blood pressure and diabetes need ongoing checks, which supports active monitored patients.
- Hospital-at-home programs: Hospitals that send acute patients home need devices and software to track them, which can raise devices deployed and recurring fees.
- Device connectivity and cost: Cheaper sensors and cellular connectivity lower the cost of each monitored patient, supporting gross margin and wider deployment.
Major Risks
- Reimbursement rule changes: Changes to billing codes or payment amounts can quickly reduce what clinics earn per patient and hence demand; watch reimbursement code coverage.
- Billing audit scrutiny: Auditors look for billing that does not match services delivered, which can lead to repayments and customer losses; watch legal notes and customer count.
- Competition from consumer wearables: Consumer watches and sensors offer similar readings at low cost and may narrow what clinical vendors can charge; watch revenue per patient.
- Clinician workload: If monitoring adds work without staff, clinics may drop programs, which lowers active patients and retention; watch customer clinic count.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | Medium |
| Industry Maturity | Growth |
| Geographic Importance | U.S. |
Companies Associated with Remote Patient Monitoring
The SEC's Standard Industrial Classification has no code that describes remote patient monitoring as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.
| Company | SEC classification | Revenue | Growth | Net margin | Year |
|---|---|---|---|---|---|
| Dexcom Inc | Surgical & Medical Instruments & Apparatus | $4.7 billion | 15.6% | 17.9% | FY 2025 |
| Teladoc Health, Inc. | Services-Offices & Clinics Of Doctors Of Medicine | $2.5 billion | -1.5% | -7.9% | FY 2025 |
| Irhythm Holdings, Inc. | Surgical & Medical Instruments & Apparatus | $747 million | 26.2% | -6.0% | FY 2025 |
Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the company directory and the health care hub.
Where to Go Next
The Remote Patient Monitoring guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Research & Manufacturing Services
- Regenerative Medicine
- Research Reagents
- Rare Disease Pharmaceuticals
- Respiratory Devices
- Rare Disease Biotechnology
- Retail Pharmacies
- Proteomics
Put it to work
Frequently Asked Questions
What are the main KPIs for the Remote Patient Monitoring industry?
Key performance indicators for the Remote Patient Monitoring industry include: Active monitored patients, Revenue per patient, Reimbursement code coverage, Gross margin, Customer clinic count. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Remote Patient Monitoring industry?
The Remote Patient Monitoring industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.
What are the biggest risks in the Remote Patient Monitoring industry?
The primary risks for Remote Patient Monitoring companies include: Reimbursement rule changes, Billing audit scrutiny, Competition from consumer wearables, Clinician workload. Investors should assess each company's exposure to these factors and its track record of navigating them.